Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07309159
PHASE1/PHASE2

Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study

Sponsor: Centre Hospitalier Charles Perrens, Bordeaux

View on ClinicalTrials.gov

Summary

This study aims to examine the dual effects of cannabis consumption on both positive and negative symptoms of schizophrenia, across laboratory and real-world contexts. By integrating ecological momentary assessment (EMA) with cognitive tasks such as reality monitoring, the research seeks to clarify how cannabis use influences symptom severity and cognitive functioning in individuals with schizophrenia. Gaining insight into these relationships may contribute to the development of more effective management strategies and ultimately improve outcomes for patients living with schizophrenia.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-06-01

Completion Date

2028-12-31

Last Updated

2026-03-16

Healthy Volunteers

No

Conditions

Interventions

OTHER

Ecological Momentary Assessment (EMA) and Reality Monitoring tasks

Use of Ecological Momentary Assessment (EMA) and a mobile Reality Monitoring task